1. Home
  2. OPTT vs TCRX Comparison

OPTT vs TCRX Comparison

Compare OPTT & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ocean Power Technologies Inc.

OPTT

Ocean Power Technologies Inc.

HOLD

Current Price

$0.29

Market Cap

76.4M

Sector

Utilities

ML Signal

HOLD

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

HOLD

Current Price

$0.93

Market Cap

75.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPTT
TCRX
Founded
1984
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.4M
75.1M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
OPTT
TCRX
Price
$0.29
$0.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$1.50
$7.00
AVG Volume (30 Days)
5.4M
416.6K
Earning Date
03-17-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
63.83
12.28
EPS
N/A
N/A
Revenue
$5,861,000.00
$10,325,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$221.57
$19.81
P/E Ratio
N/A
N/A
Revenue Growth
6.08
266.65
52 Week Low
$0.27
$0.85
52 Week High
$0.90
$2.57

Technical Indicators

Market Signals
Indicator
OPTT
TCRX
Relative Strength Index (RSI) 39.67 41.90
Support Level N/A $0.91
Resistance Level $0.45 $1.16
Average True Range (ATR) 0.02 0.07
MACD -0.01 -0.00
Stochastic Oscillator 10.38 31.00

Price Performance

Historical Comparison
OPTT
TCRX

About OPTT Ocean Power Technologies Inc.

Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

Share on Social Networks: